Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 7, 2021
Effects of the DRD2/3 antagonist ONC201 and radiation in glioblastomaLing He, Kruttika Bhat, Angeliki Ioannidis, et al.Radiation Research|June 30, 2004
A sense of danger from radiationWilliam H McBride, Chi-Shiun Chiang, Jennifer L Olson, et al.International Journal of Radiation Oncology, Biology, Physics|September 10, 2018
Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast CancerLe Zhang, Milana Bochkur Dratver, Taha Yazal, et al.Breast Cancer Research and Treatment|August 3, 2019
PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiationLe Zhang, Justine Bailleul, Taha Yazal, et al.Proceedings of the National Academy of Sciences of the United States of America|September 9, 2011
Metabolic state of glioma stem cells and nontumorigenic cellsErina Vlashi, Chann Lagadec, Laurent Vergnes, et al.Neuro-Oncology|April 16, 2020
1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine treatment after brain irradiation preserves cognitive function in miceKruttika Bhat, Paul Medina, Ling He, et al.Journal of the National Cancer Institute|February 8, 2021
Dopamine Receptor Antagonists, Radiation, and Cholesterol Biosynthesis in Mouse Models of GlioblastomaKruttika Bhat, Mohammad Saki, Fei Cheng, et al.International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trialsWendy A Woodward, Robert G Bristow, Michael F Clarke, et al.Proceedings of the National Academy of Sciences of the United States of America|May 3, 2020
The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastomaKruttika Bhat, Mohammad Saki, Erina Vlashi, et al.Cancer & Metabolism|April 26, 2018
Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilitiesMatthew Garrett, Jantzen Sperry, Daniel Braas, et al.Pageof 9